Obama’s ‘inversion’ curbs kill Pfizer’s $160 bn Allergan deal
NEW YORK: US drug maker Pfizer Inc agreed on Tuesday to terminate its 160 billion agreement to acquire Botox maker Allergan Plc in a major victory to US President Barack Obamas drive to stop taxdodging corporate mergers
Advertisement
Advertisement
Advertisement